AzTrials
AzTrials

Motor Evoked PotentialPhase 4NIOMNCT04997707

The Effect of Balanced Anesthesia Regimen on Intraoperative Trans-cranial Motor Evoked Potential During Spine Surgeries:

A Phase 4 study testing Propofol Abbott, Sevoflurane Inhalation Solution and transcranial motor evoked potential(Tcm in people with Motor Evoked Potential, run by El-Sahel Teaching Hospital at 2 sites in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

transcranial motor evoked potentials (TcMEP) were proved to be useful during complicated spinal surgeries to prevent iatrogenic complications. The effect of anesthetic agents was comprehensively discussed in literature. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Motor Evoked Potential
What is being tested?
Propofol Abbott, Sevoflurane Inhalation Solution and transcranial motor evoked potential(Tcm
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
2 sitesEgypt
Study dates
6 Apr 2017to 5 Apr 2021
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • (ASA) grades I-II who were scheduled for spinal surgeries (intraspinal tumors resection, spondylolisthesis correction, traumatic spinal fractures fixation….etc)

Who cannot join

  • Patients aged less than 18 years, or with history of drug abuse, any pulmonary disease, preoperative motor deficit, history of epilepsy, pacemakers and cochlear implants, previous intracranial surgeries or needed to deepen anesthetic plane during surgery

Trial locations and contacts

2 sites in 1 country.

Egypt2 sites
  • National cancer Institute

    Cairo, 000000

  • El sahel Teaching Hospital

    Cairo, 767565

Other trials in Egypt

About this study

Official title: The Effect of Propofol-based Anaesthesia Versus Low Dose Propofol With Less Than Half MAC Sevoflurane on Intraoperative Trans-cranial Motor Evoked Potential During Spine Surgeries: Ratios Rather Than Values.

transcranial motor evoked potentials (TcMEP) were proved to be useful during complicated spinal surgeries to prevent iatrogenic complications. The effect of anesthetic agents was comprehensively discussed in literature. The Investigators studied a new balanced anesthetic protocol using propofol and sevoflurane in addition to continuous fentanyl infusion in which they compared values and ratios of amplitudes and latencies of TcMEP waves at different time point.

Read the detailed description

This is a prospective double- blind randomized controlled study. After approval by the ethics committee at the National Cancer Institute (Cairo University) and El-Sahel Teaching Hospital (GOHTI, Cairo) and after written informed consents,46 ASA I-II patients who are scheduled for various spinal surgeries (such as: intra-spinal tumor resection, spondylolisthesis correction, traumatic spinal fractures' fixation,…) will be included in this study. Surgeons and neurophysiologists will be the same and will be blind to the anesthetic techniques in all patients.

Randomization list will be generated then patients will be randomized into two groups: control and study group.

Preoperatively, all patients will be checked for any exclusion criteria and the routine preoperative evaluation will be done. On arriving operative theater, all patients will receive 0.1 mg/kg midazolam IV. After connecting all the basic monitors' cables (NIBP, pulse oximetry and ECG) and canulating the radial artery to monitor IBP, induction of anesthesia will be done to all patients with 4μg/kg fentanyl, 2-3mg/kg propofol IV and 0.5mg/kg atracurium to facilitate endotracheal intubation. After intubation, central venous catheter( CVP), temperature probe through nasopharynx and urinary catheter will be inserted. Fentanyl infusion will be maintained in a rate of 2μg/kg/hour and will be discontinued 60 minutes before recovery.

From this time on, patients will be randomly allocated into control and study groups, each group is 30 patients; control group is the propofol (P) group and the study group is the balanced anesthesia (BA) group.

Control Group: propofol will be infused continuously in a rate of 75-100 μg/kg/min Study Group: propofol infusion in a rate of 25μg/kg/min will be given with sevoflurane. Sevoflurane concentration will be individually calculated by age-adjusted end - tidal MAC as follows: for age of 18-25 years, 26-40 years and ≥40 years MAC will be 2.6%, 2.2% and 1.8% respectively then final concentration to be delivered will be 0.2% lower than calculated half MAC.

Patients will be mechanically ventilated with O2/Air mixture (FiO2 50%) in a rate of 10-12/minute and tidal volume of 6-8 ml/kg to insure oxygen saturation (SpO2) around 99% and end-tidal CO2 between 28-35 mmHg. Body temperature must be kept between 35-37oC( Celsius degrees) using warm fluids and warming blankets.

Intraoperative fluids will be given guided by central venous pressure (CVP)and urine output.

Hypotension ( mean arterial blood pressure (MAP) ˂60 mmHg in normotensive patients or ˂70 mmHg in hypertensive patients) will be treated with Norepinephrine (Levophed®) in an infusion of 0.05-1.0μg /kg/min.

TcMEP Monitoring:

After induction, transcranial stimulation electrode will be connected at C1- C2, Cz and C3-C4 (10-10 international system) and subdermal needles inserted in the appropriate muscles, according to the scenario selected, processing will be done using NIM-SPINE™ SYSTEM (2005 Medtronic Sofamor Danek USA, Inc.). The stimulation used is a train-of-five square wave stimulation, 2ms inter-stimulus interval, 500 μs width and 40-220 mA intensity which can be increased with 10 mA steps till muscle answer potential is recorded.

The first TcMEP (R1) will be taken before positioning and surgical incision, at least 20-25 minutes after induction; fading of the neuromuscular blockade will be checked by train-of-four (TOF) and double- burst stimulation using peripheral nerve stimulator connected to the ulnar nerve.

A second reading (R2), which is the surgical baseline reading, will be taken 20 minutes later; during which positioning of the patient is done; again muscle relaxant fading is confirmed before the reading as above. A third reading (R3) will be taken after the surgical incision.

With every TcMEP reading, MAP, pulse rate, Oximetry, En-tidal CO2, nasopharyngeal temperature, ulnar train-of-four response, sevoflurane percentage concentration / propofol infusion rate and CVP will be recorded.

Comparison between R1 and R2 will be dedicated to the effect of anesthetic regimen, while subsequent readings will indicate both the effect of anesthetic regimen and any surgical insult (if any).

Decrease in every wave amplitude by more than 50% in relation to R1 and increase in latency more than 2 ms will be recorded as an alarming criterion.

On recovery:

After fulfilling the Modified Aldrete Recovery Score, patients will be discharged from postoperative recovery unit (PACU) to the intermediate care unit. All patients with an alarming criterion will be checked by neurosurgeon for any motor deficit.

Sample size estimation:

The aim of this study is to compare the effects of balanced anesthesia using low dose propofol and less than half MAC sevoflurane versus propofol based anesthesia while using medium-dose fentanyl in both techniques on TcMEP intraoperative monitoring during spine surgeries. Based on the previous paper published by Palazon et al., 2015, the difference in latency between the 2 groups was 3 with an average variability of 3. A total sample size of 46 (23 per group) will be sufficient to detect that effect size, with power 90% and 5% significance level the sample size was calculated by the G power program.

Being tested
Propofol Abbott, Sevoflurane Inhalation Solution, transcranial motor evoked potential(Tcm
Keywords
motor-evoked potentials, sevoflurane, balanced anesthesia,

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Propofol AbbottDrug

    Also called propofol

    in a rate of 75-100 μg/kg/min in P group, and 25μg/kg/min in BA group

  • Sevoflurane Inhalation SolutionDrug

    Also called sevoflurane

    in BA group will be calculated by age-adjusted end - tidal MAC as follows: for age of 18-25 years, 26-40 years and ≥40 years MAC will be 2.6%, 2.2% and 1.8% respectively then final concentration to be delivered will be 0.2% lower than calculated half MAC.

  • transcranial motor evoked potential(TcmDiagnostic test

    Also called intraoperative neurophysiological monitoring (IONM)

    using NIM-SPINE™ SYSTEM (2005 Medtronic Sofamor Danek USA, Inc.). The stimulation used is a train-of-five square wave stimulation, 2ms inter-stimulus interval, 500 μs width and 40-220 mA intensity which can be increased with 10 mA steps till muscle answer potential is recorded.

Study groups in NCT04997707
Study groupRoleWhat they receive
P groupActive comparator75-100 µg/kg/min propofol
Receives: Drug: Propofol Abbott; Diagnostic Test: transcranial motor evoked potential(Tcm
BA groupActive comparator25ug/kg/min propofol and 0.2% below corrected-to-age- half MAC of sevoflurane
Receives: Drug: Propofol Abbott; Drug: Sevoflurane Inhalation Solution; Diagnostic Test: transcranial motor evoked potential(Tcm

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. TcMEP Monitoring (R1)

    The first TcMEP (R1) was taken before positioning and surgical incision, at least 20-25 min

    Measured: " up to 45 minutes"

  2. TcMEP Monitoring(R2)

    R2), after positioning of the patient

    Measured: "up to 60 minutes"

  3. TcMEP Monitoring(R3)

    (R3) was taken after the surgical incision

    Measured: " up to 75 minutes"

Secondary outcomes (13)
  1. Mean arterial blood pressure (MAP)

    in mmHg

    Measured: " up to 5 hours"

  2. pulse rate

    number / minute

    Measured: " up to 5 hours"

  3. Spo2

    in percentage

    Measured: " up to 5 hours"

  4. temperature

    in C

    Measured: " up to 5 hours"

  5. propofol infusion rate

    ml/hour

    Measured: " up to 5 hours"

  6. end-tidal sevoflurane

    percentage

    Measured: " up to 5 hours"

  7. Central venous pressure (CVP)

    cmH2O

    Measured: " up to 5 hours"

  8. end-tidal CO2

    mmHg

    Measured: " up to 5 hours"

  9. PaO2

    mmHg

    Measured: " up to 5 hours"

  10. PaCo2

    mmHg

    Measured: " up to 5 hours"

  11. PHa

    Number

    Measured: " up to 5 hours"

  12. Train-of-four stimulation ( TOF)

    percentage

    Measured: " up to 5 hours"

  13. R3/R2 ratio

    percentage

    Measured: " up to 5 hours"

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Aug 2021
  2. Study start6 Apr 2017
  3. Primary completion5 Mar 2020
  4. Study completion5 Apr 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Care provider, Outcomes assessor
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04997707
Sponsor's protocol ID
322018
Acronym
NIOM
Status last verified
Jul 2021
First submitted
14 Jul 2021
Last updated
10 Aug 2021
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Methods and results

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Propofol Abbott, Sevoflurane Inhalation Solution and transcranial motor evoked potential(Tcm in people with Motor Evoked Potential, run by El-Sahel Teaching Hospital at 2 sites in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Aug 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

TcMEP Monitoring (R1) (time frame: " up to 45 minutes"). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Aug 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in